Keesha Kaplan, PA
Medical · Las Vegas, NVNPI 1366758153
Payments from drug & device makers
Across 551 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- UCB, Inc.$1K
- Pfizer$802
- Dermavant Sciences, Inc.$777
- Sanofi$771
- plus $4K from 25 others
What the payments were for
- Food & beverage$10,29593%
- Education$8087%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 123 | $2,271 |
| Johnson & Johnson | 62 | $1,476 |
| UCB, Inc. | 41 | $1,020 |
| Pfizer | 52 | $802 |
| Dermavant Sciences, Inc. | 32 | $777 |
| Sanofi | 34 | $771 |
| Sun Pharmaceutical Industries Inc. | 18 | $592 |
| LEO Pharma Inc. | 33 | $567 |
| Novartis | 26 | $474 |
| E.r. Squibb & Sons, L.L.C. | 57 | $395 |
| Galderma Laboratories, L.p. | 17 | $350 |
| Merz North America, Inc. | 5 | $232 |
| Lilly USA, LLC | 9 | $226 |
| Arcutis Biotherapeutics, Inc. | 5 | $201 |
| Organon | 9 | $150 |
| Revance Therapeutics, Inc. | 1 | $115 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Incyte Corporation | 3 | $98 |
| Stemline Therapeutics Inc. | 1 | $57 |
| VYNE Pharmaceuticals Inc. | 1 | $55 |
| GSK | 2 | $53 |
| Kyowa Kirin, Inc. | 2 | $52 |
| Krystal Biotech Inc | 2 | $47 |
| Verrica Pharmaceuticals Inc. | 2 | $42 |
| Botanix SB Inc | 2 | $35 |
| Strata Skin Sciences, Inc. | 2 | $30 |
| Amgen | 2 | $27 |
| Recordati_rare_diseases_inc. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Blueprint Medicines Corporation | 1 | $19 |
| Dermira, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,103 in reported general payments places this provider in the 95th percentile of 250 medical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $94,978 |
| Humira PenAdalimumab | 11 | $76,538 |
| Dupixent PenDupilumab | 13 | $49,742 |
| Clobetasol Propionate | 263 | $8,429 |
| Tretinoin | 66 | $6,215 |
| Ketoconazole | 354 | $4,610 |
| Triamcinolone Acetonide | 292 | $4,605 |
| Doxycycline Monohydrate | 102 | $3,565 |
| Mometasone Furoate | 130 | $2,162 |
| Clindamycin Phosphate | 51 | $1,394 |
| Mupirocin | 188 | $1,296 |
| Fluocinolone Acetonide | 18 | $1,117 |
| Metronidazole | 16 | $1,075 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 16 | $762 |
| Fluocinonide | 20 | $758 |
Paid to pharmacies, not to this prescriber.
Other medical in Las Vegas
- John NotabartoloLas Vegas$284K
- Rachel BowersLas Vegas$29K
- Spencer MeierLas Vegas$24K
- Megan WieselLas Vegas$19K
- Tai PhamLas Vegas$16K
- Eric HilmesLas Vegas$15K
- Wardon OjedapoLas Vegas$12K
- Melchor GochiocoLas Vegas$11K
- Adelbert WadsworthLas Vegas$11K
- Isaac TunnellLas Vegas$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.